David Tepper and 33 Other Funds Bought Software Stocks. CoreWeave Is Down 43% Since. Time to Buy?

CoreWeave's stock has fallen 43% since August, with analysts cutting targets. NVIDIA's CEO resignation and yield concerns add risk. Oracle and Core Scientific face similar challenges. ServiceNow and Akamai reported mixed results. CoreWeave's next loan yield and NVIDIA's report are key to watch.

Original reporting
Published Nov 17, 2026, 2:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 2:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
David Tepper and 33 Other Funds Bought Software Stocks. CoreWeave Is Down 43% Since. Time to Buy? — source image
Decision brief

The 30-second read

$CRWVBearishMed
01

Why it matters

CoreWeave’s expected next loan yield and dependency on NVIDIA capacity support are the key near-term risk drivers. ServiceNow and Akamai provide counterpoints via guidance and margin signals, while Oracle and Core Scientific are discussed through backlog and contractual exposure to the same AI build-out.

02

Market read

Traders can use the article’s specific financing-yield expectation for CoreWeave and the guidance/margin datapoints for ServiceNow and Akamai to reassess near-term risk and valuation assumptions.

03

What to watch

The article emphasizes analyst targets and financing yields but does not quantify CoreWeave’s liquidity runway or contract renegotiation terms; for Oracle and NVIDIA, the linkage is described rather than evidenced by a new contract change.

Relevance 6/10Novelty 5/10Timing: ahead of mid-February next 13F updates; immediate focus on CoreWeave’s next loan yield and NVIDIA’s first report under Kress

Background

The piece frames a post-IPO AI infrastructure drawdown for CoreWeave, with analyst target cuts and financing-cost repricing, while contrasting with software and networking peers’ own guidance and margin developments.

Company-level read

Ticker impact

$CRWVBearishHigh confidence
Context

CoreWeave’s next contract-backed loan is expected to price at a 7% to 7.5% yield, raising dilution and lender-share risk as chips support is uncertain.

Expected impact

Likely downside or continued volatility as the market prices higher cost of capital and uncertain capacity support.

Evidence & confidence

The article ties CoreWeave’s funding economics directly to a new loan yield expectation and highlights a key dependency on NVIDIA’s post-resignation leadership decisions.

$NOWNeutralMedium confidence
Context

ServiceNow guided fourth-quarter cRPO growth to 18.5% versus ~19.8% expected, while raising its AI annual contract value target to $1.7 billion.

Expected impact

Likely modest pressure or choppy trading as investors weigh the cRPO miss against AI ACV strength.

Evidence & confidence

The article provides both a specific guidance shortfall and an offsetting AI ACV increase, implying competing signals for near-term valuation.

$AKAMBearishMedium confidence
Context

Akamai reported Q3 revenue growth to $1.12 billion, saw non-GAAP operating margin fall to 25%, and cut full-year revenue guidance.

Expected impact

Likely downside bias as the market reprices full-year revenue and margin trajectory.

Evidence & confidence

The article explicitly states a full-year revenue guidance cut and margin decline, which typically dominate over discretionary insider buying.

$ORCLNeutralLow confidence
Context

Oracle is described as having OpenAI as about half its backlog, with OpenAI’s latest funding round reaching $15 billion, while Oracle’s average target has fallen sharply.

Expected impact

Likely range-bound to slightly negative as investors focus on the lowered analyst targets despite the OpenAI backlog linkage.

Evidence & confidence

The piece links Oracle to OpenAI backlog and funding, but it does not present a fresh Oracle-specific operational disclosure beyond analyst-target movement.

$CORZBearishMedium confidence
Context

Core Scientific leases about 590 megawatts to CoreWeave under 12-year contracts worth $10.2 billion, while its total debt has roughly quadrupled since December.

Expected impact

Likely negative bias as debt growth and exposure to CoreWeave economics raise perceived risk.

Evidence & confidence

The article provides a concrete debt deterioration and a direct contractual linkage to CoreWeave capacity.

$NVDANeutralLow confidence
Context

Jensen Huang resigned as NVIDIA’s CEO, and the article notes NVIDIA supplies CoreWeave’s chips and rents back its capacity.

Expected impact

Likely limited direct impact on NVDA unless investors infer changes to supply or capacity economics; could add volatility around the dependency narrative.

Evidence & confidence

The article’s NVDA details are largely contextual to CoreWeave’s risk, not a new NVDA-specific policy or contract change.

Market effects

Reinforces that AI infrastructure financing costs and customer concentration risk are central to valuation, pressuring highly levered operators while rewarding cash-generative software.

Primarily US-listed growth and software complex; sentiment spillover into AI infrastructure and enterprise SaaS.

Highlights global AI supply-chain dependencies (chip supply and capacity leasing) that can affect cross-border AI capex narratives.

Counterpoint

CoreWeave’s higher loan yield could be a one-time repricing, and ServiceNow’s AI ACV target raise may outweigh the cRPO guide softness, supporting selective dip-buying.

Key entities

  • CoreWeave

    AI infrastructure provider facing higher expected contract-backed loan yields and uncertainty around NVIDIA support.

  • ServiceNow

    Enterprise software firm with slightly light cRPO guidance but raised AI annual contract value target.

  • Akamai

    Networking/CDN company that cut full-year revenue guidance after margin compression.

  • Oracle

    Enterprise software firm with OpenAI-linked backlog exposure and sharply lower analyst targets.

  • Core Scientific

    Leased-power counterparty to CoreWeave with rapidly rising debt.

Related articles

$NOWMed

ServiceNow Sees AI Usage Surge as It Raises Annual Contract Value Target to $1.7 Billion

ServiceNow (NYSE: NOW) reported a surge in AI usage, raising its annual contract value target to $1.7 billion. The company is shifting towards consumption-based pricing and expanding AI capabilities across its product tiers. ServiceNow's AI tools aim to reach budgets beyond traditional IT spending, with potential to augment worker productivity. The company is also focusing on AI governance and supporting customers using other interfaces.

$COHRMed

Lumentum, Corning and other optical-related stocks jump on Chinese import restrictions

US optical equipment stocks like Coherent Corp. (COHR), Applied Optoelectronics (AAOI), Lumentum Holdings (LITE), and Corning (GLW) rose 2-3% on reports of US import restrictions on Chinese data center equipment, per Reuters. The FCC raised concerns about data theft. Tech giants like Amazon (AMZN), Google (GOOGL), and Meta (META) opposed the move. Separately, Nvidia (NVDA) formed a committee for national security policies and export controls ahead of its earnings release.

$NVDAMed

US moves to block China's indirect access to American AI tech

The US issued new rules to restrict China's access to advanced American computing chips and servers, targeting remote access via overseas data centers. The move follows Nvidia CEO Jensen Huang's resignation amid scrutiny of chip diversions to China. Data centers in countries like Malaysia must now identify end users, with additional licensing for sales to high-risk countries. The US aims to close loopholes in export controls, preventing China from accessing advanced AI chips.